Ginkgo Bioworks Holdings, Inc.
DNA · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $562 | $944 | $1,316 | $1,550 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $22 | $18 | $84 | $150 |
| Inventory | $0 | $0 | $4 | $3 |
| Other Curr. Assets | $19 | $19 | $9 | $1 |
| Total Curr. Assets | $603 | $1,002 | $1,450 | $1,723 |
| Property Plant & Equip (Net) | $598 | $395 | $719 | $146 |
| Goodwill | $0 | $49 | $60 | $21 |
| Intangibles | $73 | $83 | $111 | $22 |
| Long-Term Investments | $49 | $78 | $112 | $115 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $55 | $59 | $87 | $44 |
| Total NC Assets | $775 | $664 | $1,089 | $348 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,377 | $1,665 | $2,539 | $2,071 |
| Liabilities | – | – | – | – |
| Payables | $14 | $9 | $10 | $8 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $31 | $48 | $48 | $33 |
| Other Curr. Liab. | $27 | $54 | $53 | $40 |
| Total Curr. Liab. | $107 | $164 | $173 | $135 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $99 | $158 | $175 | $156 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $17 | $24 | $42 | $191 |
| Total NC Liab. | $554 | $404 | $630 | $369 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $468 | $239 | $443 | $23 |
| Total Liabilities | $661 | $568 | $803 | $504 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$5,838 | -$5,291 | -$4,398 | -$2,298 |
| AOCI | -$2 | $1 | -$3 | -$2 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $716 | $1,097 | $1,736 | $1,505 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $62 |
| Total Liab. & Tot. Equity | $1,377 | $1,665 | $2,539 | $2,071 |
| Net Debt | -$562 | -$944 | -$1,316 | -$1,550 |